Panitumumab Added to Docetaxel, Cisplatin and Fluoropyrimidine in Oesophagogastric Cancer: ATTAX3 Phase II Trial

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2015.440

Related search